THYQUIDITY Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Thyquidity patents expire, and what generic alternatives are available?
Thyquidity is a drug marketed by Azurity and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has eleven patent family members in eleven countries.
The generic ingredient in THYQUIDITY is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thyquidity
A generic version of THYQUIDITY was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for THYQUIDITY
International Patents: | 11 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 52 |
Patent Applications: | 620 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for THYQUIDITY |
What excipients (inactive ingredients) are in THYQUIDITY? | THYQUIDITY excipients list |
DailyMed Link: | THYQUIDITY at DailyMed |


Pharmacology for THYQUIDITY
Drug Class | l-Thyroxine |
Anatomical Therapeutic Chemical (ATC) Classes for THYQUIDITY
Paragraph IV (Patent) Challenges for THYQUIDITY
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
THYQUIDITY | Oral Solution | levothyroxine sodium | 100 mcg/5 mL | 214047 | 1 | 2022-12-28 |
US Patents and Regulatory Information for THYQUIDITY
THYQUIDITY is protected by one US patents.
Patents protecting THYQUIDITY
Method for the preparation of a levothyroxine solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | THYQUIDITY | levothyroxine sodium | SOLUTION;ORAL | 214047-001 | Nov 30, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for THYQUIDITY
See the table below for patents covering THYQUIDITY around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Serbia | 54524 | POSTUPAK PRIPREME RASTVORA LEVOTIROKSINA (METHOD FOR THE PREPARATON OF A LEVOTHYROXINE SOLUTION) | ⤷ Try a Trial |
European Patent Office | 2683361 | MÉTHODE DE MANUFACTURE D'UNE SOLUTION DE LÉVOTHYROXINE (METHOD FOR THE PREPARATON OF A LEVOTHYROXINE SOLUTION) | ⤷ Try a Trial |
Cyprus | 1117151 | ⤷ Try a Trial | |
Poland | 2683361 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |